Table 2.
Primary outcomes and secondary outcomes.
| Abdominal bandage group | Conventional group | p value | |
|---|---|---|---|
| BBPS score | 6.38 ± 0.94 | 6.14 ± 0.95 | 0.11a |
| BS score | 8.51 ± 0.98 | 8.48 ± 0.99 | 0.71a |
| Withdraw time (s) | 421.00 (369.00–548.00) | 418.00 (370.00–550.00) | 0.96b |
| Adverse events, n (%) | 0 | 0 | 1c |
| CIT (s) | 279.00 (234.50–305.75) | 421.00 (327.00–485.00) | <0.001b |
| CCR, n (%) | 116 (96.7%) | 105 (88.2%) | 0.01d |
|
| |||
| Diagnosis, n (%) | |||
| Normal | 42 (35.0%) | 51(42.9%) | 0.65e |
| Adenoma | 57 (47.5%) | 39 (32.8%) | <0.001e |
| Advanced adenoma | 2 (1.7%) | 2 (1.7%) | 1e |
| Adenocarcinoma | 1 (0.8%) | 1 (0.8%) | 1e |
| Polyps | 9 (7.5%) | 17 (14.3%) | 0.32e |
| IBD | 2 (1.7%) | 1(0.8%) | 1e |
| Others | 7 (5.8%) | 8 (6.7%) | 0.99e |
Note. BBPS, Boston Bowel Preparation Scale; BS, Bubble Scale; CIT, cecal insertion time; CCR, complete colonoscopy rate; IBD, inflammatory bowel disease; aStudent's t-test; bMann–Whitney test; cFisher's exact test; dPearson's χ2 test; eBonferroni method χ2 test.